{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:25:10Z","timestamp":1767140710751,"version":"build-2238731810"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T00:00:00Z","timestamp":1571702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Tumor Centre Dresden","award":["none"],"award-info":[{"award-number":["none"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00384-019-03396-x","type":"journal-article","created":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:28:17Z","timestamp":1571790497000},"page":"1895-1905","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term results achieved by guideline-based stage-dependent management of anal cancer in a non-HIV population"],"prefix":"10.1007","volume":"34","author":[{"given":"Bernhard","family":"Fankhaenel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joerg","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothea","family":"Bleyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Puffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kittner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Witzigmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-196X","authenticated-orcid":false,"given":"Sigmar","family":"Stelzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"3396_CR1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.ejso.2016.02.253","volume":"42","author":"M Alfa-Wali","year":"2016","unstructured":"Alfa-Wali M, Dalla Pria A, Nelson M, Tekkis P, Bower M (2016) Surgical excision alone for stage T1 anal verge cancers in people living with HIV. Eur J Surg Oncol 42:813\u2013816","journal-title":"Eur J Surg Oncol"},{"key":"3396_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.suc.2009.09.008","volume":"90","author":"K Garrett","year":"2010","unstructured":"Garrett K, Kalady MF (2010) Anal neoplasms. Surg Clin N Am 90:147\u2013161","journal-title":"Surg Clin N Am"},{"issue":"Suppl 3","key":"3396_CR3","doi-asserted-by":"publisher","first-page":"iii 10","DOI":"10.1093\/annonc\/mdu159","volume":"25","author":"R Glynne-Jones","year":"2014","unstructured":"Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, Arnold D (2014) Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 25(Suppl 3):iii 10\u2013iii 20","journal-title":"Ann Oncol"},{"key":"3396_CR4","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1590\/S0004-28032011000200010","volume":"48","author":"F Gimenez","year":"2011","unstructured":"Gimenez F, Costa-e-Silva IT, Daumas A, Araujo J, Medeiros SG, Ferreira L (2011) The value of high-resolution anoscopy in the diagnosis of anal cancer precursor lesions in HIV-positive patients. Arq Gastroenterol 48:136\u2013145","journal-title":"Arq Gastroenterol"},{"key":"3396_CR5","doi-asserted-by":"publisher","first-page":"O234","DOI":"10.1111\/codi.12553","volume":"16","author":"JR Wilkinson","year":"2014","unstructured":"Wilkinson JR, Morris EJ, Downing A, Aravani A, Thomas JD, Sebag-Montefiore D (2014) The rising incidence of anal cancer in England 1990-2010: a population-based study. Color Dis 16:O234\u2013O239","journal-title":"Color Dis"},{"key":"3396_CR6","doi-asserted-by":"publisher","first-page":"206","DOI":"10.12816\/0006000","volume":"6","author":"SA Salati","year":"2012","unstructured":"Salati SA, Al Kadi A (2012) Anal cancer\u2014a review. Int J Health Sci (Qassim) 6:206\u2013230","journal-title":"Int J Health Sci (Qassim)"},{"key":"3396_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1007\/BF02586980","volume":"17","author":"ND Nigro","year":"1974","unstructured":"Nigro ND, Vaitkevicius VK, Considine B Jr (1974) Combined therapy for cancer of the anal canal: a preliminary report. Dis Colon Rectum 17:354\u2013356","journal-title":"Dis Colon Rectum"},{"key":"3396_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s40487-016-0024-0","volume":"4","author":"R Glynne-Jones","year":"2016","unstructured":"Glynne-Jones R, Saleem W, Harrison M, Mawdsley S, Hall M (2016) Background and current treatment of squamous cell carcinoma of the anus. Oncol Ther 4:135\u2013172","journal-title":"Oncol Ther"},{"key":"3396_CR9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s11912-013-0296-6","volume":"15","author":"A Aggarwal","year":"2013","unstructured":"Aggarwal A, Duke S, Glynne-Jones R (2013) Anal cancer: are we making progress? Curr Oncol Rep 15:170\u2013181","journal-title":"Curr Oncol Rep"},{"key":"3396_CR10","unstructured":"National Comprehensive Cancer Network NCCN (2016) Clinical practice guidelines in oncology, anal carcinoma. Version I.2017. \nhttp:\/\/www.nccn.org\n\n. Accessed 25 May 2018"},{"key":"3396_CR11","first-page":"190","volume-title":"Kurzgefasste interdisziplin\u00e4re Leitlinien 2004. Diagnostik und Therapie maligner Erkrankungen","author":"B Schmitt-Reisser","year":"2004","unstructured":"Schmitt-Reisser B (2004) In: Krebsgesellschaft D (ed) Kurzgefasste interdisziplin\u00e4re Leitlinien 2004. Diagnostik und Therapie maligner Erkrankungen, 4th edn. Zuckschwerdt, M\u00fcnchen, pp 190\u2013198","edition":"4"},{"key":"3396_CR12","unstructured":"Deutsche Aids-Gesellschaft e.V. (DAIG) (2013) Deutsch-\u00d6sterreichische Leitlinie: Anale Dysplasien und Analkarzinome bei HIV-Infizierten: Pr\u00e4vention, Diagnostik, Therapie. \nhttp:\/\/www.awmf.org\/uploads\/tx_szleitlinien\/055-007l_S1k_Anale_Dysplasien_Analkarzinom_HIV_infizierten_09-2013__01.pdf\n\n. Accessed 15 Nov 2018"},{"key":"3396_CR13","first-page":"77","volume-title":"TNM classification of malignant tumors","author":"JD Brierley","year":"2016","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C (2016) Anal canal and perianal skin. In: Brierley JD, Gospodarowicz MK, Wittekind C (eds) TNM classification of malignant tumors, 8th edn. Wiley-Blackwell, Chichester, pp 77\u201380","edition":"8"},{"key":"3396_CR14","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1245\/s10434-014-3849-5","volume":"21","author":"CB Geltzeiler","year":"2014","unstructured":"Geltzeiler CB, Nabavizadeh N, Kim J, Kim CL, Billingsley KG, Thomas CR, Herzig DO, Tsikitis VL (2014) Chemoradiotherapy with a radiation boost for anal cancer decreases the risk for salvage abdominoperineal resection: analysis from the national cancer data base. Ann Surg Oncol 21:3616\u20133620","journal-title":"Ann Surg Oncol"},{"key":"3396_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.ejso.2016.05.006","volume":"42","author":"Y Alamri","year":"2016","unstructured":"Alamri Y, Buchwald P, Dixon L, Dobbs B, Eglinton T, McCormick J, Wakeman C, Frizelle FA (2016) Salvage surgery in patients with recurrent or residual squamous cell carcinoma of the anus. Eur J Surg Oncol 42:1687\u20131692","journal-title":"Eur J Surg Oncol"},{"key":"3396_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/cncr.27825","volume":"119","author":"R Glynne-Jones","year":"2013","unstructured":"Glynne-Jones R, Sebag-Montefiore D, Adams R, Gollins S, Harrison M, Meadows HM, Jitlal M (2013) Prognostic factors for recurrence and survival in anal cancer: generating hypotheses from the mature outcomes of the first United Kingdom Coordinating Committee on Cancer Research Anal Cancer Trial (ACT I). Cancer 119:748\u2013755","journal-title":"Cancer"},{"key":"3396_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(13)70086-X","volume":"14","author":"RD James","year":"2013","unstructured":"James RD, Glynne-Jones R, Meadows HM, Cunningham D, Myint AS, Saunders MP, Maughan T, McDonald A, Essapen S, Leslie M, Falk S, Wilson C, Gollins S, Begum R, Ledermann J, Kadalayil L, Sebag-Montefiore D (2013) Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 \u00d7 2 factorial trial. Lancet Oncol 14:516\u2013524","journal-title":"Lancet Oncol"},{"key":"3396_CR18","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.1200\/JCO.2012.43.8085","volume":"30","author":"LL Gunderson","year":"2012","unstructured":"Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG (2012) Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil\/mitomycin versus fluorouracil\/cisplatin. J Clin Oncol 30:4344\u20134351","journal-title":"J Clin Oncol"},{"key":"3396_CR19","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2011.35.4837","volume":"30","author":"D Peiffert","year":"2012","unstructured":"Peiffert D, Tournier-Rangeard L, G\u00e9rard JP, Lemanski C, Fran\u00e7ois E, Giovannini M, Cvitkovic F, Mirabel X, Bouch\u00e9 O, Luporsi E, Conroy T, Montoto-Grillot C, Mornex F, Lusinchi A, Hannoun-L\u00e9vi JM, Seitz JF, Adenis A, Hennequin C, Denis B, Ducreux M (2012) Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial. J Clin Oncol 30:1941\u20131948","journal-title":"J Clin Oncol"},{"key":"3396_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s10350-007-9093-3","volume":"51","author":"PR Fleshner","year":"2008","unstructured":"Fleshner PR, Chalasani S, Chang GJ, Levien DH, Hyman NH, Buie WD, Standards Practice Task Force, American Society of Colon and Rectal Surgeons (2008) Practice parameters for anal squamous neoplasms. Dis Colon Rectum 51:2\u20139","journal-title":"Dis Colon Rectum"},{"key":"3396_CR21","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1097\/DCR.0b013e318255815e","volume":"55","author":"SR Steele","year":"2012","unstructured":"Steele SR, Varma MG, Melton GB, Ross HM, Rafferty JF, Buie WD, Standards Practice Task Force of the American Society of Colon and Rectal Surgeons (2012) Practice parameters for anal squamous neoplasms. Dis Colon Rectum 55:735\u2013749","journal-title":"Dis Colon Rectum"},{"issue":"Suppl 5","key":"3396_CR22","doi-asserted-by":"publisher","first-page":"v87","DOI":"10.1093\/annonc\/mdq171","volume":"21","author":"R Glynne-Jones","year":"2010","unstructured":"Glynne-Jones R, Northover JMA, Cervantes A (2010) Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v87\u2013v92","journal-title":"Ann Oncol"},{"key":"3396_CR23","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00053-019-0378-5","volume":"41","author":"A Madlung","year":"2019","unstructured":"Madlung A (2019) Radiotherapy of anal and rectal cancer. Squamous cell anal carcinoma from a radiologic perspective. Coloproctology 41:255\u2013261","journal-title":"Coloproctology"},{"key":"3396_CR24","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/cncr.28055","volume":"119","author":"M Williams","year":"2013","unstructured":"Williams M, Swampillai A, Osborne M, Mawdsley S, Hughes R, Harrison M, Harvey R, Glynne-Jones R (2013) Squamous cell carcinoma antigen: a potentially useful prognostic marker in squamous cell carcinoma of the anal canal and margin. Cancer 119:2391\u20132398","journal-title":"Cancer"},{"key":"3396_CR25","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.soc.2016.07.001","volume":"26","author":"VM Nelson","year":"2017","unstructured":"Nelson VM, Benson AB 3rd (2017) Epidemiology of anal canal cancer. Surg Oncol Clin N Am 26:9\u201315","journal-title":"Surg Oncol Clin N Am"},{"key":"3396_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058919","volume":"8","author":"ES Amirian","year":"2013","unstructured":"Amirian ES, Fickey PA Jr, Scheurer ME, Chiao EY (2013) Anal cancer incidence and survival: comparing the greater San-Francisco bay area to other SEER cancer registries. PLoS One 8:e58919","journal-title":"PLoS One"},{"key":"3396_CR27","unstructured":"Statistisches Landesamt Sachsen (2017) Bev\u00f6lkerung 2017. \nhttps:\/\/www.statistik.sachsen.de\/html\/426.htm\n\n. Accessed 01 June 2019"},{"key":"3396_CR28","unstructured":"Robert-Koch-Institut (2018) HIV\/AIDS Eckdaten \nhttps:\/\/www.rki.de\/DE\/Content\/InfAZ\/H\/HIVAIDS\/Eckdaten\/Eckdaten.htmlHIV\/AIDS\n\n in Sachsen\u2014Eckdaten der Sch\u00e4tzung. Accessed 01 June 2019"},{"key":"3396_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/DCR.0000000000000555","volume":"59","author":"E Kim","year":"2016","unstructured":"Kim E, Kim JS, Choi M, Thomas CR Jr (2016) Conditional survival in anal carcinoma using the National Population-Based Survey of epidemiology and end results database (1988-2012). Dis Colon Rectum 59:291\u2013298","journal-title":"Dis Colon Rectum"},{"key":"3396_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/DCR.0b013e31819eb7f0","volume":"52","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Rock CE, Stewart AK, Ko CY, Halverson A (2009) Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis Colon Rectum 52:624\u2013631","journal-title":"Dis Colon Rectum"},{"key":"3396_CR31","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1001\/jama.299.16.1914","volume":"299","author":"JA Ajani","year":"2008","unstructured":"Ajani JA, Winter KA, Gunderson LL, Pedersen J, Benson AB 3rd, Thomas CR Jr, Mayer RJ, Haddock MG, Rich TA, Willett CG (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299:1914\u20131921","journal-title":"JAMA"},{"key":"3396_CR32","doi-asserted-by":"publisher","first-page":"e607","DOI":"10.1016\/j.ijrobp.2011.02.042","volume":"81","author":"AB Chakravarthy","year":"2011","unstructured":"Chakravarthy AB, Catalano PJ, Martenson JA, Mondschein JK, Wagner H, Mansour EG, Talamonti MS, Benson AB 3rd (2011) Long-term follow-up of a phase II trial of high-dose radiation with concurrent 5-fluorouracil and cisplatin in patients with anal cancer (ECOG E4292). Int J Radiat Oncol Biol Phys 81:e607\u2013e613","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3396_CR33","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.critrevonc.2016.03.001","volume":"101","author":"JB Delhorme","year":"2016","unstructured":"Delhorme JB, Antoni D, Mak KS, Severac F, Freel KC, Schumacher C, Rohr S, Brigand C, Noel G (2016) Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers. Crit Rev Oncol Hematol 101:131\u2013138","journal-title":"Crit Rev Oncol Hematol"},{"key":"3396_CR34","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/codi.12222","volume":"15","author":"DA Harris","year":"2013","unstructured":"Harris DA, Williamson J, Davies M, Evans MD, Drew P, Beynon J (2013) Outcome of salvage surgery for anal squamous cell carcinoma. Color Dis 15:968\u2013973","journal-title":"Color Dis"},{"key":"3396_CR35","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00384-016-2575-9","volume":"31","author":"J Hardt","year":"2016","unstructured":"Hardt J, Mai S, Wei\u00df C, Kienle P, Magdeburg J (2016) Abdominoperineal resection and perineal wound healing in recurrent, persistent, or primary anal carcinoma. Int J Color Dis 31:1197\u20131203","journal-title":"Int J Color Dis"},{"key":"3396_CR36","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10350-008-9361-x","volume":"51","author":"P Mariani","year":"2008","unstructured":"Mariani P, Ghanneme A, De la Rochefordi\u00e8re A, Girodet J, Falcou MC, Salmon RJ (2008) Abdominoperineal resection for anal cancer. Dis Colon Rectum 51:1495\u20131501","journal-title":"Dis Colon Rectum"},{"key":"3396_CR37","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/DCR.0b013e31819eefa6","volume":"52","author":"ME Hogg","year":"2009","unstructured":"Hogg ME, Popowich DA, Wang EC, Kiel KD, Stryker SJ, Halverson AL (2009) HIV and anal cancer outcomes: a single institution\u2019s experience. Dis Colon Rectum 52:891\u2013897","journal-title":"Dis Colon Rectum"},{"key":"3396_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s00384-015-2474-5","volume":"31","author":"S Hannes","year":"2016","unstructured":"Hannes S, Reinisch A, Bechstein WO, Habbe N (2016) Salvage abdominoperineal excisions in recurrent anal cancer--impact of different reconstruction techniques on outcome, morbidity, and complication rates. Int J Color Dis 31:653\u2013659","journal-title":"Int J Color Dis"},{"key":"3396_CR39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/DCR.0000000000001010","volume":"61","author":"GR Guerra","year":"2018","unstructured":"Guerra GR, Kong JC, Bernardi MP, Ramsay RG, Phillips WA, Warrier SK, Lynch AC, Ngan SY, Heriot AG (2018) Salvage surgery for locoregional failure in anal squamous cell carcinoma. Dis Colon Rectum 61:179\u2013186","journal-title":"Dis Colon Rectum"},{"key":"3396_CR40","first-page":"209","volume":"153","author":"CY Chai","year":"2018","unstructured":"Chai CY, Tran Cao HS, Awad S, Massarweh NN (2018) Management of stage I squamous cell carcinoma of the anal canal. JAMA 153:209\u2013215","journal-title":"JAMA"},{"key":"3396_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1055\/s-2004-836942","volume":"17","author":"GJ Chang","year":"2004","unstructured":"Chang GJ, Welton ML (2004) Human papillomavirus, condylomata acuminata, and anal neoplasia. Clin Colon Rectal Surg 17:221\u2013230","journal-title":"Clin Colon Rectal Surg"},{"key":"3396_CR42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12962-017-0073-8","volume":"15","author":"FS Mennini","year":"2017","unstructured":"Mennini FS, Bonanni P, Bianic F, de Waure C, Baio G, Plazzotta G, Uhart M, Rinaldi A, Largeron N (2017) Cost-effectiveness analysis of the nine-valent HPV vaccine in Italy. Cost Eff Resour Alloc 15:11","journal-title":"Cost Eff Resour Alloc"},{"key":"3396_CR43","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1038\/sj.bjc.6603469","volume":"95","author":"LL Villa","year":"2006","unstructured":"Villa LL, Costa RL, Petta CA et al (2006) High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6\/11\/16\/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 95:1459\u20131466","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.1007\/s00384-020-03714-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000}}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-019-03396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-019-03396-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-019-03396-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T19:13:05Z","timestamp":1603221185000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-019-03396-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,22]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["3396"],"URL":"https:\/\/doi.org\/10.1007\/s00384-019-03396-x","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,22]]},"assertion":[{"value":"10 September 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of the article mentioned above found out errors on the Table 4 concerning the number and survival rates of patients with incomplete radiotherapy.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}